Opexa Therapeutics, Inc.·4

Feb 9, 4:29 PM ET

Williams Jimmy Calvin 4

4 · Opexa Therapeutics, Inc. · Filed Feb 9, 2009

Insider Transaction Report

Form 4
Period: 2009-02-06
Williams Jimmy Calvin
Chief Operating Officer
Transactions
  • Award

    Common Stock Option (right to buy)

    2009-02-06+28,643162,573 total
    Exercise: $0.47From: 2009-02-06Exp: 2019-02-06Common Stock (28,643 underlying)
Footnotes (1)
  • [F1]For services rendered to Issuer as an executive officer.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT